| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 632 | 11.991 | 11.725 | 12.167 | 17.164 | 19.329 |
| Total Income - EUR | - | 0 | 0 | 0 | 632 | 11.991 | 11.725 | 23.117 | 39.402 | 28.496 |
| Total Expenses - EUR | - | 329 | 0 | 0 | 0 | 6.196 | 8.154 | 18.804 | 34.290 | 21.875 |
| Gross Profit/Loss - EUR | - | -329 | 0 | 0 | 632 | 5.795 | 3.571 | 4.313 | 5.112 | 6.621 |
| Net Profit/Loss - EUR | - | -329 | 0 | 0 | 613 | 5.435 | 3.262 | 4.021 | 4.718 | 5.561 |
| Employees | - | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 1 |
Check the financial reports for the company - Pharmatherapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.069 | 1.051 | 1.031 | 1.012 | 55.442 | 52.155 | 48.240 | 44.029 | 39.873 |
| Current Assets | - | 8.987 | 8.835 | 8.672 | 9.137 | 8.013 | 21.273 | 20.438 | 16.736 | 15.407 |
| Inventories | - | 8.596 | 8.451 | 8.296 | 8.135 | 0 | 24 | 1.082 | 1.701 | 489 |
| Receivables | - | 0 | 0 | 0 | 632 | 7.443 | 20.933 | 19.241 | 14.289 | 6.304 |
| Cash | - | 390 | 384 | 376 | 369 | 570 | 316 | 115 | 746 | 8.614 |
| Shareholders Funds | - | -3.689 | -3.627 | -3.560 | -2.878 | 6.078 | 9.205 | 13.255 | 17.932 | 23.393 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 13.745 | 13.512 | 13.264 | 13.026 | 57.377 | 64.224 | 55.423 | 42.833 | 31.887 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharmatherapy S.r.l.